StreetInsider.com News Articles

Form 4 Astrana Health, Inc. For: Oct 10 Filed by: Vong John

Tue, 13 Oct 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20261013/27181308.html

Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership

Sat, 10 Oct 2026 15:05:00 -0400

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)-- Verda Healthcare, Inc. is proud to announce a new partnership with AstranaCare Partners of Arizona and AstranaCare Partners of Texas. AstranaCare, through a large network of Independent Physician Associations (IPAs), enables providers to deliver high-quality care, efficiently with supportive local resources and technology tools that allow providers to focus more on patient care rather than administrative tasks. Astrana Health, the parent company, has over 20,000 in-network providers and manages over 1.6 million lives. This alliance extends to Arizona and Texas, signifying a significant step forward in advancing the quality and accessibility of healthcare

Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership

Sat, 10 Oct 2026 15:05:00 -0400

Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call

Fri, 09 Oct 2026 16:05:00 -0400

ALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2026, after the close of the stock market on Thursday, November 5, 2026. The Company will discuss those results on a

Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call

Fri, 09 Oct 2026 16:05:00 -0400

Form 4 Astrana Health, Inc. For: Oct 06 Filed by: Sim Brandon

Thu, 08 Oct 2026 20:11:00 -0400

si-local-file:///var/storage/secattach/20261008/27168011.html

Form 4 Astrana Health, Inc. For: Oct 06 Filed by: Lam Thomas S.

Thu, 08 Oct 2026 19:21:00 -0400

si-local-file:///var/storage/secattach/20261008/27167968.html

Form 4 Astrana Health, Inc. For: Oct 02 Filed by: Basho Chandan

Tue, 06 Oct 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20261006/27151364.html

Form 8-K Astrana Health, Inc. For: Sep 23

Wed, 23 Sep 2026 08:06:00 -0400

si-local-file:///var/storage/secattach/20260923/27093631.html

Form 8-K Astrana Health, Inc. For: Sep 22

Wed, 23 Sep 2026 07:30:00 -0400

si-local-file:///var/storage/secattach/20260923/27093337.html

Form 4 Astrana Health, Inc. For: Sep 15 Filed by: Vong John

Thu, 17 Sep 2026 17:53:00 -0400

si-local-file:///var/storage/secattach/20260917/27076971.html

Astrana Health (ASTH) Mentioned as short at Glass House

Thu, 17 Sep 2026 10:01:08 -0400

(Updated - September 17, 2026 10:01 AM EDT)

Astrana Health (NASDAQ: ASTH) Mentioned as short at Glass House

"We Are Short Astrana Health Astrana's profit depends on an unusual stack of management estimates — reserves, PPA marks, ACO settlements, receivables, and adjusted earnings. We think that subjectivity is masking a weaker business."

Astrana Health (ASTH) Mentioned as short at Glass House

Thu, 17 Sep 2026 10:01:08 -0400

(Updated - September 17, 2026 10:01 AM EDT)

Astrana Health (NASDAQ: ASTH) Mentioned as short at Glass House

"We Are Short Astrana Health Astrana's profit depends on an unusual stack of management estimates — reserves, PPA marks, ACO settlements, receivables, and adjusted earnings. We think that subjectivity is masking a weaker business."

Form 8-K Astrana Health, Inc. For: Sep 15

Tue, 15 Sep 2026 08:46:00 -0400

si-local-file:///var/storage/secattach/20260915/27061866.html

Oppenheimer Starts Astrana Health, Inc (ASTH) at Outperform

Tue, 15 Sep 2026 06:17:01 -0400

Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health, Inc (NASDAQ: ASTH) with a Outperform rating and a price target of $53.00.

For an analyst ratings summary and ratings history on Astrana Health, Inc click here. For more ratings news on Astrana Health, Inc click here.

Shares of Astrana Health, Inc closed at $39.60 yesterday.

Form 4 Astrana Health, Inc. For: Aug 14 Filed by: Schmidt David

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944464.html

Form 4 Astrana Health, Inc. For: Aug 14 Filed by: Schmidt David

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944464.html

Form 3 Astrana Health, Inc. For: Aug 07 Filed by: Vong John

Tue, 11 Aug 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260811/26907264.html

Form 3 Astrana Health, Inc. For: Aug 07 Filed by: Vong John

Tue, 11 Aug 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260811/26907264.html

Form 4 Astrana Health, Inc. For: Aug 07 Filed by: Sobotka Glenn

Tue, 11 Aug 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260811/26906977.html

Form 4 Astrana Health, Inc. For: Aug 07 Filed by: Sobotka Glenn

Tue, 11 Aug 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260811/26906977.html

Astrana Health, Inc (ASTH) PT Raised to $55 at Truist Securities

Tue, 11 Aug 2026 09:41:59 -0400

(Updated - August 11, 2026 9:41 AM EDT)

Truist Securities analyst Jailendra Singh raised the price target on Astrana Health, Inc (NASDAQ: ASTH) to $55.00 (from $47.00) while maintaining a Buy rating.

The analyst commented: "Investing Today's Outperformance for Tomorrow's Growth; Bottom Line. We came away from the quarter with greater confidence that ASTH’s underlying execution remains strong and that the company is increasingly shifting from integration toward its next phase of growth. Prospect is largely integrated, retention and synergy realization remain solid, and consolidated medical cost trends continue to track favorably, while stable Medicare utilization, AI-enabled operating efficiencies, and continued full-risk

Astrana Health, Inc (ASTH) PT Raised to $55 at Truist Securities

Tue, 11 Aug 2026 09:41:59 -0400

(Updated - August 11, 2026 9:41 AM EDT)

Truist Securities analyst Jailendra Singh raised the price target on Astrana Health, Inc (NASDAQ: ASTH) to $55.00 (from $47.00) while maintaining a Buy rating.

Form 10-Q Astrana Health, Inc. For: Jun 30

Mon, 10 Aug 2026 17:04:00 -0400

http://archive.fast-edgar.com/20260810/AA22U22FZZ2R8TZ2229S2ZYMGPIKEZ22N282

Filed on: August 10, 2026

Form 10-Q Astrana Health, Inc. For: Jun 30

Mon, 10 Aug 2026 17:04:00 -0400

http://archive.fast-edgar.com/20260810/AA22U22FZZ2R8TZ2229S2ZYMGPIKEZ22N282

Filed on: August 10, 2026